The China Radiology Service Market was valued at $321.6 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $919.8 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the China Radiology Service Market are Peking Union Medical College Hospital, Shanghai Huashan Hospital, Guangzhou Medical University Affiliated Cancer Hospital, Fudan University Shanghai Cancer Centre, Beijing Cancer Hospital, and Shanghai Renji Hospital, among others.
The China Biobanks Market was valued at $6,168.90 Mn in 2023 and is predicted to grow at a CAGR of 10.30% from 2023 to 2030, to $12,252.90 Mn by 2030. The key drivers of this industry include government support, rising chronic diseases, and research and development initiatives. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
The Germany Cancer Induced Bone Disease Therapeutics Market was valued at $48 Mn in 2022 and is predicted to grow at a CAGR of 4% from 2023 to 2030, to $65 Mn by 2030. The key drivers of this industry include the rising prevalence of different cancers, advancements in diagnostics, and a robust healthcare system. The industry is primarily dominated by players such as Amgen, Novartis, Pfizer, Roche, Eli Lilly, Pharmalucence, and Bayer, among others.
The Vietnam Periodontal Therapeutics Market was valued at $4.4 Mn in 2023 and is predicted to grow at a CAGR of 7.43% from 2023 to 2030, to $7.2 Mn by 2030. Vietnam Periodontal Therapeutics Market is growing due to Rising Awareness About Dental Hygiene, Economic Growth and Rising Disposable Income and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
The Indonesia Radiology Service Market was valued at $24 Mn in 2023 and is predicted to grow at a CAGR of 14.7% from 2023 to 2030, to $62.7 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and healthcare infrastructure development. The prominent players of the Indonesia Radiology Service Market are Rumah Sakit Cipto Mangunkusumo (RSCM), Rumah Sakit Pondok Indah, Rumah Sakit Siloam, Rumah Sakit Mitra Keluarga, and Rumah Sakit Pusat Pertamina (RSPP), among others.
The Indonesia Biobanks Market was valued at $460.44 Mn in 2023 and is predicted to grow at a CAGR of 8.80% from 2023 to 2030, to $830.95 Mn by 2030. The key drivers of this industry include growing healthcare needs, the national genome project, and the private sector. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
Brazil Chronic Cough Therapeutics Market was valued at $158 Mn in 2022 and is estimated to reach $316 Mn in 2030, exhibiting a CAGR of 9.1% during the forecast period. The main driver behind the growth of the chronic cough therapeutics market is the extensive prevalence of chronic respiratory infections, often signaled by the occurrence of chronic cough. Presently, key participants in this market consist of GlaxoSmithKline (GSK), Pfizer, McNeil Consumer Healthcare (Johnson & Johnson), Procter & Gamble (P&G), Reckitt Benckiser Group, Perrigo Company, Medtech Products Inc., Bionpharma Inc., A. Vogel Canada Inc., and Jamieson Laboratories.
The Egypt Periodontal Therapeutics Market was valued at $2.4 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $4.4 Mn by 2030. Egypt Periodontal Therapeutics Market is growing due to Rising Awareness About Dental Hygiene, Prevalence of periodontitis and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
The Japan Radiology Service Market was valued at $248.6 Mn in 2023 and is predicted to grow at a CAGR of 15.2% from 2023 to 2030, to $669.5 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Japan Radiology Service Market are Tokyo Medical University Hospital, Keio University Hospital, Osaka University Hospital, Kyoto University Hospital, and National Cancer Center Hospital, among others
The Japan Biobanks Market was valued at $4,770.05 Mn in 2023 and is predicted to grow at a CAGR of 9.30% from 2023 to 2030, to $8,889.24 Mn by 2030. The key drivers of this industry include government support, increasing demand for biomedical research, and a high prevalence of diseases. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
The South Africa Periodontal Therapeutics Market was valued at $5.7 Mn in 2023 and is predicted to grow at a CAGR of 8.43% from 2023 to 2030, to $10 Mn by 2030. South Africa Periodontal Therapeutics Market is growing due to Increasing Awareness Dental Hygiene, periodontitis Prevalence, and Advancing Treatment Technologies. The market is primarily dominated by players such as Dental365, Smile Dental, The Dental Spa, Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, and Sun Pharmaceutical Industries Ltd.
The Malaysia Radiology Service Market was valued at $6.4 Mn in 2023 and is predicted to grow at a CAGR of 14.9% from 2023 to 2030, to $17 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Malaysia Radiology Service Market are KPJ Damansara Specialty Hospital, Mahkota Medical Centre, Gleneagles Intan Medical Centre, Sunway Medical Centre, and Gleneagles Medical Centre Penang, among others.
China Chronic Cough Therapeutics Market was valued at $506 Mn in 2022 and is estimated to reach $1054 Mn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The key driver behind the growth of the chronic cough therapeutics market is the prevalent occurrence of chronic respiratory infections, often identified by persistent coughing. Leading participants in this market presently include Hengan Group, Guangzhou Pharmaceutical Holdings, Shanghai Fosun Pharmaceutical, Beijing Tongrentang Group, Merck, AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis and GlaxoSmithKline.
The Kenya Periodontal Therapeutics Market was valued at $0.6 Mn in 2023 and is predicted to grow at a CAGR of 8.3% from 2023 to 2030, to $1.1 Mn by 2030. Kenya Periodontal Therapeutics Market is growing due to Rising Awareness About Dental Hygiene, Prevalence of periodontitis, and Rising Disposable Income. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
The Philippines Radiology Service Market was valued at $8.8 Mn in 2023 and is predicted to grow at a CAGR of 15.2% from 2023 to 2030, to $23.7 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness on early diagnosis. The prominent players of the Philippines Radiology Service Market are Philippine General Hospital, St. Luke's Medical Centre, Makati Medical Centre, Asian Hospital and Medical Centre, The Medical City, and Cardinal Santos Medical Centre, among others.
The Malaysia Biobanks Market was valued at $123.38 Mn in 2023 and is predicted to grow at a CAGR of 9% from 2023 to 2030, to $225.54 Mn by 2030. The key drivers of this industry include disease burden, technological advancements, and national genome projects. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
Egypt Chronic Cough Therapeutics Market was valued at $18 Mn in 2022 and is estimated to reach $37 Mn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The predominant factor driving the growth of the chronic cough therapeutics market is the prevalent occurrence of persistent coughing associated with chronic respiratory infections. Leading entities in this sector currently include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, Sanofi, Merck & Co., AstraZeneca, Abbott Laboratories, Bayer AG, and Chiesi Farmaceutici.
The India Periodontal Therapeutics Market was valued at $15.9 Mn in 2023 and is predicted to grow at a CAGR of 10.2% from 2023 to 2030, to $31.3 Mn by 2030. India Periodontal Therapeutics Market is growing due to Increasing disposable income and healthcare expenditure, Growing dental tourism, and Technological Advancements. The market is primarily dominated by players such as Sun Pharmaceutical Industries Ltd, Cipla, Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, and Bausch Health Companies Inc.
The Singapore Radiology Service Market was valued at $4.8 Mn in 2023 and is predicted to grow at a CAGR of 15.3% from 2023 to 2030, to $13 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Singapore Radiology Service Market are Mount Elizabeth Hospital, National University Hospital (NUH)-Singapore, Gleneagles Hospital, Mount Elizabeth Novena Hospital, Parkway East Hospital, Mount Alvernia Hospital, among others.
The Vietnam Biobanks Market was valued at $383.70 Mn in 2023 and is predicted to grow at a CAGR of 9.03% from 2023 to 2030, to $702.77 Mn by 2030. The key drivers of this industry include a focus on precision medicine and genetic testing, increasing disease burden, and national genome projects. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
France Chronic Cough Therapeutics Market was valued at $173 Mn in 2022 and is estimated to reach $300 Mn in 2030, exhibiting a CAGR of 7.1% during the forecast period. The primary factor propelling the expansion of the chronic cough therapeutics market is the widespread occurrence of chronic respiratory infections, commonly indicated by the presence of persistent coughing. Currently, prominent players in this market include Boiron, AstraZeneca, GlaxoSmithKline, Sanofi, Pfizer, Merck, Johnson & Johnson, Novartis, Teva Pharmaceutical Industries, and Pierre Fabre Laboratories.
The Canada MRI Market was valued at $531.20 Mn in 2023 and is predicted to grow at a CAGR of 6.5% from 2023 to 2030, to $825.48 Mn by 2030. The key drivers of this industry include rising prevalence of chronic diseases, technological advancements, and increasing government expenditure. The key players in the industry are Siemens Healthineers, Neusoft, Hitachi High-Tech Corporation, and GE Healthcare among others.
The Vietnam Radiology Service Market was valued at $20 Mn in 2023 and is predicted to grow at a CAGR of 14.93% from 2023 to 2030, to $53 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and healthcare infrastructure development. The prominent players of the Vietnam Radiology Service Market are Vinmec International General Hospital, Cuc International General Hospital, Saint Paul Hospital, Hue Central Hospital (HCH), Hoan My Da Nang Hospital, and Franco-Vietnamese (FV) Hospital, among others.
The India Biobanks Market was valued at $1,395.59 Mn in 2023 and is predicted to grow at a CAGR of 11.80% from 2023 to 2030, to $3,046.85 Mn by 2030. The key drivers of this industry include government support, the rising prevalence of chronic disease, and advancements in personalized medicine. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Hamilton Company among others.
Germany Chronic Cough Therapeutics Market was valued at $231 Mn in 2022 and is estimated to reach $376 Mn in 2030, exhibiting a CAGR of 6.3% during the forecast period. The primary factor propelling the expansion of the chronic cough therapeutics market is the widespread occurrence of chronic respiratory infections, commonly indicated by the presence of persistent coughing. Currently, prominent players in this market include Boiron, AstraZeneca, GlaxoSmithKline, Sanofi, Pfizer, Merck, Johnson & Johnson, Novartis, Teva Pharmaceutical Industries, and Pierre Fabre Laboratories.